AKT1 and cancer: Specifically, we recently demonstrated that, in contrast to the established role of SHIP1 as a negative regulator, HCMV uses SHIP1 to stimulate a noncanonical activation of Akt similar to cancer cells [72,73,74] in order to mediate the survival of infected monocytes [30].